A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Nashville, TN · +73 more sites
21 recruiting obesity studies with a site in Nashville, TN.
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Nashville, TN · +73 more sites
Sponsor: AbbVie
Bristol, TN · Knoxville, TN · +56 more sites
Sponsor: Alveus Therapeutics, Inc.
Nashville, TN · +19 more sites
Sponsor: Hoffmann-La Roche
Clarksville, TN · Nashville, TN · +42 more sites
Sponsor: Eli Lilly and Company
Nashville, TN · +39 more sites
Sponsor: Eli Lilly and Company
Knoxville, TN · Nashville, TN · +78 more sites
Sponsor: Eli Lilly and Company
Nashville, TN · +49 more sites
Sponsor: Eli Lilly and Company
Nashville, TN · +49 more sites
Sponsor: Hoffmann-La Roche
Nashville, TN · +2 more sites
Sponsor: Novo Nordisk A/S
Jackson, TN · Kingsport, TN · Memphis, TN · +96 more sites
Sponsor: Eli Lilly and Company
Nashville, TN · +40 more sites
Sponsor: Vanderbilt University Medical Center
Nashville, TN · +1 more sites
Sponsor: Vanderbilt University Medical Center
Nashville, TN
Sponsor: Vanderbilt University Medical Center
Nashville, TN
Sponsor: Icahn School of Medicine at Mount Sinai
Nashville, TN · +2 more sites
Sponsor: VA Office of Research and Development
Nashville, TN
Sponsor: Vanderbilt University
Nashville, TN
Sponsor: Vanderbilt University Medical Center
Nashville, TN
Sponsor: Vanderbilt University Medical Center
Nashville, TN
Sponsor: Vanderbilt University Medical Center
Nashville, TN
Sponsor: Vanderbilt University Medical Center
Nashville, TN
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.